Literature DB >> 9795880

Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies.

A J Schwab1, W Geng, K S Pang.   

Abstract

The dispersion model (DM) is a stochastic model describing the distribution of blood-borne substances within organ vascular beds. It is based on assumptions of concurrent convective and random-walk (pseudodiffusive) movements in the direction of flow, and is characterized by the mean transit time (t) and the dispersion number (inverse Peclet number), DN. The model is used with either closed (reflective) boundary conditions at the inflow and the outflow point (Danckwerts conditions) or a closed condition at the inflow and an open (transparent) condition at the outflow (mixed conditions). The appropriateness of DM was assessed with outflow data from single-pass perfused rat liver multiple indicator dilution (MID) experiments, with varying lengths of the inflow and outflow catheters. The studies were performed by injection, of bolus doses of 51Crlabeled red blood cells (vascular indicator), 125I-labeled albumin and [14C] sucrose (interstitual indicators), and [3H]2O (whole tissue indicator) into the portal vein at a perfusion rate of 12 ml/ min. The outflow profiles based on the DM were convolved with the transport function of the catheters, then fitted to the data. A fairly good fit was obtained for most of the MID curve, with the exception of the late-in-time data (prolonged tail) beyond 3 x [symbol: see text]. The fitted DNS were found to differ among the indicators, and not with the length of the inflow and outflow catheters. But the differences disappeared when a delay parameter, t0 = 4.1 +/- 0.7 sec (x +/- SD), was included as an additional fitted parameter for all of the indicators except water. Using the short catheters, the average DN for the model with delay was 0.31 +/- 0.13 for closed and 0.22 +/- 0.07 for mixed boundary conditions, for all reference indicators. Mean transit times and the variances of the fitted distributions were always smaller than the experimental ones (on average, by 6.8 +/- 3.7% and 58 +/- 19%, respectively). In conclusion, the DM is a reasonable descriptor of dispersion for the early-in-time data and not the late-in-time data. The existence of a common DN for all noneliminated reference indicators suggests that intrahepatic dispersion depends only on the geometry of the vasculature rather than the diffusional processes. The role of the nonsinusoidal ("large") vessels can be partly represented by a simple delay.

Entities:  

Mesh:

Year:  1998        PMID: 9795880     DOI: 10.1023/a:1020557706994

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  61 in total

1.  Computationally efficient algorithms for convection-permeation-diffusion models for blood-tissue exchange.

Authors:  J B Bassingthwaighte; I S Chan; C Y Wang
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

2.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 2. Effect of pharmacological agents, retrograde perfusions, and enzyme inhibition on evans blue, sucrose, water, and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

3.  Modeling blood flow heterogeneity.

Authors:  R B King; G M Raymond; J B Bassingthwaighte
Journal:  Ann Biomed Eng       Date:  1996 May-Jun       Impact factor: 3.934

4.  Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).

Authors:  Y Yano; K Yamaoka; Y Aoyama; H Tanaka
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

5.  A convection-diffusion model of indicator transport through an organ.

Authors:  W Perl; F P Chinard
Journal:  Circ Res       Date:  1968-02       Impact factor: 17.367

6.  Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.

Authors:  A B Ahmad; P N Bennett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

7.  The series-compartment model for hepatic elimination.

Authors:  M R Gray; Y K Tam
Journal:  Drug Metab Dispos       Date:  1987 Jan-Feb       Impact factor: 3.922

8.  Hepatic elimination--dispersion model.

Authors:  M S Roberts; M Rowland
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

9.  Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.

Authors:  M S Ching; D J Morgan; R A Smallwood
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

10.  A compartmental model to quantitate in vivo glucose transport in the human forearm.

Authors:  C Cobelli; M P Saccomani; E Ferrannini; R A Defronzo; R Gelfand; R Bonadonna
Journal:  Am J Physiol       Date:  1989-12
View more
  3 in total

1.  Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

Authors:  M S Roberts; Y G Anissimov
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

3.  Fractal structure of the liver: effect on drug elimination.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-05       Impact factor: 2.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.